MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jpet.2026.105008

Медицинская библиотека · The Journal of pharmacology and experimental therapeutics · 2026

Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.

Slivicki Richard A, Wang Justin G, Kucz Kayla V, Hines Jakayla Folarin, Tran Nhat Vy Trinh, Kravitz Alexxai V, Creed Meaghan C, Gereau Robert W

СтатьяПеревод в очереди

Аннотация

Oxycodone is commonly prescribed for moderate-to-severe pain. While efficacious, long-term use can result in tolerance, physical dependence, and opioid use disorder. Cannabis and Δ9-tetrahydrocannabinol (Δ9-THC) have been reported to potentiate oxycodone-induced antinociception in animals and humans. Whether Δ9-THC also facilitates unwanted aspects of oxycodone intake, such as tolerance, dependence, and reward at antinociceptive doses, remains unclear. We evaluated the coadministration of Δ9-THC and oxycodone on antinociception, dependence, circadian activity, and reward in male and female mice. Oxycodone and Δ9-THC produced dose-dependent antinociception in the hotplate assay, with oxycodone showing lower potency in females. Repeated treatment (twice daily for 5 days) produced antinociceptive tolerance. Δ9-THC produced a potentiation-like effect on oxycodone-induced antinociception and delayed antinociceptive tolerance. Repeated oxycodone produced physical dependence and alterations in circadian activity, neither of which was exacerbated by cotreatment with Δ9-THC. Combination treatment of oxycodone and Δ9-THC produced conditioned place preference at doses that did not produce preference when administered alone. Fiber photometry recordings of nucleus accumbens dopamine release showed that Δ9-THC potentiated oxycodone-evoked dopamine release at subeffective oxycodone doses, a candidate mechanism for the behavioral reward potentiation. These data indicate that Δ9-THC may facilitate oxycodone-induced antinociception without augmenting certain unwanted features of opioid intake (eg, dependence and circadian rhythm alterations). However, Δ9-THC also recruited the rewarding properties of oxycodone at therapeutically relevant doses. These reward-related findings indicate that Δ9-THC and oxycodone combinations may carry increased abuse liability, a primary consideration for their therapeutic evaluation. SIGNIFICANCE STATEMENT: In mice, Δ9-tetrahydrocannabinol (Δ9-THC) produced a potentiation-like effect on oxycodone-induced antinociception and delayed antinociceptive tolerance without exacerbating opioid dependence or circadian disruption, but Δ9-THC also produced conditioned place preference and potentiated nucleus accumbens dopamine release at subeffective oxycodone doses. These findings indicate that Δ9-THC may enhance oxycodone-induced antinociception, but also that Δ9-THC recruits the rewarding properties of oxycodone at doses that are otherwise subeffective. The increased abuse liability of such combinations is a primary consideration for their therapeutic evaluation.

Для цитирования: Slivicki Richard A, Wang Justin G, Kucz Kayla V, Hines Jakayla Folarin, Tran Nhat Vy Trinh, Kravitz Alexxai V, Creed Meaghan C, Gereau Robert W. Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.. The Journal of pharmacology and experimental therapeutics. 2026. DOI: 10.1016/j.jpet.2026.105008.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.